STAGE II RECTAL CANCER AJCC V8
Clinical trials for STAGE II RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for tough rectal cancers
Disease control OngoingThis study tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) along with a short course of radiation can shrink advanced rectal cancers before surgery. It includes 31 adults with a specific genetic type of rectal cancer (MSI-H/dMMR) that has spread locally. T…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for HIV patients with anal cancer: personalized treatment aims to cut recurrence
Disease control OngoingThis study tests a risk-adapted approach for people with HIV and anal cancer. Low-risk patients receive standard chemotherapy and radiation, while high-risk patients also get the immunotherapy drug nivolumab after standard treatment to help prevent the cancer from coming back. Th…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Cancer's hidden cost: study reveals financial toll on patients
Knowledge-focused OngoingThis study looks at the financial burden faced by people with stage I-III colon or rectal cancer who are being treated with the goal of a cure. Researchers will track how patients' finances and quality of life change over time by collecting survey data. The goal is to help doctor…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC